TELA - TELA Bio GAAP EPS of -$0.63 misses by $0.04 revenue of $11.9M in-line
2023-05-11 16:13:08 ET
- TELA Bio press release ( NASDAQ: TELA ): Q1 GAAP EPS of -$0.63 misses by $0.04 .
- Revenue of $11.9M (+44.6% Y/Y) in-line.
- 2023 Financial Guidance
- We continue to expect full year 2023 revenue to range from $60 million to $65 million vs $61.80M consensus
For further details see:
TELA Bio GAAP EPS of -$0.63 misses by $0.04, revenue of $11.9M in-line